AKEBIA THERAPEUTICS, INC. (AKBA) Operating income 2016–2025
AKEBIA THERAPEUTICS, INC. (AKBA) annual operating income history from SEC filings — each fiscal year as reported.
$23.5MFY2025 · since FY2016: -$136.5M → $23.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $23.5M | +146.6% |
| FY2024 | -$50.5M | -9.1% |
| FY2023 | -$46.3M | +42.7% |
| FY2022 | -$80.8M | +69.5% |
| FY2021 | -$264.5M | +30.0% |
| FY2020 | -$377.8M | -32.0% |
| FY2019 | -$286.3M | -60.7% |
| FY2018 | -$178.2M | -132.4% |
| FY2017 | -$76.7M | +43.8% |
| FY2016 | -$136.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice